Original Article
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis: Subgroup analysis of Latin American patients in the phase 3 randomized UNCOVER-3 study
Comparación de ixekizumab y etanercept o placebo en la psoriasis de moderada a grave: análisis del subgrupo de pacientes latinoamericanos de la fase 3 del estudio aleatorizado UNCOVER-3
F. Valenzuelaa, C. de la Cruz Fernandezb, R.L. Galimbertic, S. Gürbüzd, M. McKean-Matthewse, L. Goncalvesf,
, R. Romitig
Corresponding author
a Departamento de Dermatología, Facultad de Medicina Universidad de Chile, Probity Medical Research, Santiago, Chile
b Clinica Dermacross, Santiago, Chile
c Universidad de Buenos Aires Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
d Eli Lilly and Company, Indianapolis, USA
e inVentiv Health, USA
f Eli Lilly and Company, São Paulo, Brazil
g Department of Dermatology, Hospital das Clínicas de Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Read
5358
Timeswas read the article
2157
Total PDF
3201
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 81 | 53 | 134 |
| 2024 October | 73 | 48 | 121 |
| 2024 September | 65 | 22 | 87 |
| 2024 August | 94 | 46 | 140 |
| 2024 July | 85 | 36 | 121 |
| 2024 June | 68 | 33 | 101 |
| 2024 May | 71 | 32 | 103 |
| 2024 April | 75 | 26 | 101 |
| 2024 March | 69 | 27 | 96 |
| 2024 February | 58 | 28 | 86 |
| 2024 January | 55 | 32 | 87 |
| 2023 December | 50 | 15 | 65 |
| 2023 November | 60 | 29 | 89 |
| 2023 October | 56 | 17 | 73 |
| 2023 September | 59 | 35 | 94 |
| 2023 August | 38 | 10 | 48 |
| 2023 July | 57 | 37 | 94 |
| 2023 June | 45 | 21 | 66 |
| 2023 May | 41 | 34 | 75 |
| 2023 April | 41 | 21 | 62 |
| 2023 March | 72 | 30 | 102 |
| 2023 February | 65 | 20 | 85 |
| 2023 January | 42 | 34 | 76 |
| 2022 December | 90 | 43 | 133 |
| 2022 November | 49 | 28 | 77 |
| 2022 October | 30 | 14 | 44 |
| 2022 September | 23 | 28 | 51 |
| 2022 August | 23 | 44 | 67 |
| 2022 July | 34 | 35 | 69 |
| 2022 June | 39 | 20 | 59 |
| 2022 May | 39 | 34 | 73 |
| 2022 April | 38 | 55 | 93 |
| 2022 March | 52 | 51 | 103 |
| 2022 February | 28 | 35 | 63 |
| 2022 January | 31 | 59 | 90 |
| 2021 December | 33 | 41 | 74 |
| 2021 November | 33 | 52 | 85 |
| 2021 October | 37 | 58 | 95 |
| 2021 September | 39 | 51 | 90 |
| 2021 August | 40 | 42 | 82 |
| 2021 July | 43 | 38 | 81 |
| 2021 June | 40 | 30 | 70 |
| 2021 May | 47 | 62 | 109 |
| 2021 April | 82 | 68 | 150 |
| 2021 March | 72 | 54 | 126 |
| 2021 February | 59 | 51 | 110 |
| 2021 January | 41 | 45 | 86 |
| 2020 December | 48 | 26 | 74 |
| 2020 November | 45 | 43 | 88 |
| 2020 October | 35 | 21 | 56 |
| 2020 September | 38 | 28 | 66 |
| 2020 August | 28 | 26 | 54 |
| 2020 July | 44 | 29 | 73 |
| 2020 June | 29 | 39 | 68 |
| 2020 May | 16 | 14 | 30 |
| 2020 April | 21 | 24 | 45 |
| 2020 March | 23 | 19 | 42 |
| 2020 February | 3 | 0 | 3 |
| 2020 January | 3 | 0 | 3 |
| 2019 December | 8 | 0 | 8 |
| 2019 November | 2 | 0 | 2 |
| 2019 September | 10 | 0 | 10 |
| 2019 August | 4 | 0 | 4 |
| 2019 July | 4 | 0 | 4 |
| 2019 June | 6 | 0 | 6 |
| 2019 May | 9 | 0 | 9 |
| 2019 April | 17 | 0 | 17 |
| 2019 March | 3 | 0 | 3 |
| 2019 February | 2 | 0 | 2 |
| 2019 January | 5 | 0 | 5 |
| 2018 December | 18 | 0 | 18 |
| 2018 November | 10 | 0 | 10 |
| 2018 October | 21 | 0 | 21 |
| 2018 September | 2 | 0 | 2 |
| 2018 May | 1 | 0 | 1 |
| 2018 February | 26 | 5 | 31 |
| 2018 January | 26 | 7 | 33 |
| 2017 December | 36 | 14 | 50 |
| 2017 November | 40 | 12 | 52 |
| 2017 October | 28 | 15 | 43 |
| 2017 September | 30 | 29 | 59 |
| 2017 August | 40 | 43 | 83 |
| 2017 July | 46 | 37 | 83 |
| 2017 June | 12 | 2 | 14 |
Show all
